Literature DB >> 20861616

Overestimation of lumbar spine calcium with dual energy X-ray absorptiometry scanning due to the prescription of lanthanum carbonate in patients with chronic kidney disease.

Antje Fürstenberg1, John Buscombe, Andrew Davenport.   

Abstract

BACKGROUND/AIMS: Dual energy X-ray absorptiometry (DEXA) scanning is used to assess bone mineral content and diagnose osteoporosis. We had noted anecdotal cases of patients attending for DEXA scanning following recent ingestion of barium-containing radiocontrast media, resulting in spuriously increased bone mineral content. Lanthanum carbonate is prescribed to chronic kidney disease patients as a non-calcium-containing phosphate binder, and as lanthanum is denser than barium, we wondered whether this could affect DEXA scan bone mineral estimations.
METHODS: DEXA scan records were reviewed from a cohort of 169 chronic dialysis patients, 24 (14%) of whom were prescribed lanthanum carbonate.
RESULTS: Estimation of segmental bone mineral content by DEXA was similar between the groups for the arms, legs, ribs, thoracic spine, hips and pelvis, apart from the lumbar spine for which it was greater for the lanthanum group (1.05 ± 0.05 vs. 0.98 ± 0.01 gm/cm², p < 0.05). Similarly, T and Z scores were higher in the lanthanum group for the lumbar spine (T score: -0.2 ± 0.4 vs. -0.92 ± 0.1; Z score: 0.68 ± 0.4 vs. -0.01 ± 0.1; p < 0.05), but not different for the hip (T score: -1.108 ± 0.28 vs. -0.966 ± 0.09; Z: score -0.49 ± 0.25 vs. -0.3 ± 0.01).
CONCLUSION: DEXA scanning in patients prescribed lanthanum can lead to an erroneously high estimation of bone mineral content in areas of the skeleton adjacent to the bowel when the electron beam meets lanthanum.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861616     DOI: 10.1159/000320481

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  6 in total

1.  Aortic pulse wave velocity is greater in peritoneal dialysis patients with lower dual energy X-ray absorptiometry (DXA) femoral neck bone mineral density.

Authors:  Kamonwan Tangvoraphonkchai; Andrew Davenport
Journal:  J Nephrol       Date:  2018-12-10       Impact factor: 3.902

2.  Correction.

Authors: 
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-14       Impact factor: 8.237

3.  Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study.

Authors:  Nadine Heimgartner; Nicole Graf; Diana Frey; Lanja Saleh; Rudolf P Wüthrich; Marco Bonani
Journal:  Kidney Blood Press Res       Date:  2020-09-30       Impact factor: 2.687

4.  The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients.

Authors:  Takashi Shigematsu; Yuri Nakashima; Masaki Ohya; Koichi Tatsuta; Daisuke Koreeda; Wataru Yoshimoto; Shintaro Yamanaka; Toshifumi Sakaguchi; Yoshiyuki Hanba; Toru Mima; Shigeo Negi
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-05-29

5.  Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.

Authors:  Hanne Skou Jørgensen; Simon Winther; Morten Bøttcher; Ellen-Margrethe Hauge; Lars Rejnmark; My Svensson; Per Ivarsen
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

Review 6.  Lanthanum Carbonate Opacities-A Systematic Review.

Authors:  Jan Kampmann; Nina Pirschel Hansen; Anders Nikolai Ørsted Schultz; Andreas Hjelm Brandt; Frans Brandt
Journal:  Diagnostics (Basel)       Date:  2022-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.